Table 2.
Association between CFR and MAFLD
| Variables | Model I | Model II | ||
|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | |
| Carbohydrate (g), n (%) | ||||
| < 188.30 | Ref | Ref | ||
| 188.30–281.09 | 1.14 (0.91–1.44) | 0.232 | 1.30 (0.89–1.92) | 0.166 |
| > 281.09 | 1.24 (0.98–1.57) | 0.069 | 1.32 (0.76–2.30) | 0.307 |
| Fiber (g), n (%) | ||||
| < 11.15 | Ref | Ref | ||
| 11.15–18.4 | 0.91 (0.73–1.13) | 0.379 | 0.69 (0.52–0.91) | 0.011 |
| > 18.4 | 0.95 (0.74–1.24) | 0.707 | 0.69 (0.43–1.13) | 0.134 |
| CFR, n (%) | ||||
| < 12.58 | Ref | Ref | ||
| 12.58–19.91 | 1.20 (0.94–1.55) | 0.142 | 1.20 (0.87–1.66) | 0.258 |
| > 19.91 | 1.36 (1.01–1.84) | 0.049 | 1.59 (1.11–2.26) | 0.013 |
Model I, a univariate model; Model II, a multivariate model, adjusted for age, gender, race, education, marital status, smoking, physical activity, sedentary time, diabetes, hypertension, dyslipidemia, ALT, ALP, AST, GGT, BMI, and energy
CFR Carbohydrate to fiber ratio, MAFLD Metabolic dysfunction-associated fatty liver disease, ALT Alanine aminotransferase, ALP Alkaline phosphatase, AST Aspartate aminotransferase, GGT Gamma-glutamyl transferase, BMI Body mass index, OR Odds ratio, CI Confidence level, Ref Reference